Dr. Zaman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8 Richland Medical Park Drive
Suite 425
Columbia, SC 29203Phone+1 803-545-5447
Education & Training
- Prisma Health/University of South Carolina SOM Columbia (Columbia)Fellowship, Cardiovascular Disease, 2021 - 2024
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2018 - 2021
- Campbell University School of Osteopathic MedicineClass of 2018, DO, Summa Cum Laude
- George Mason UniversityBS, Biology , Magna Cum Laude, 2009 - 2013
Certifications & Licensure
- NY State License 2023 - 2025
- SC State License 2021 - 2024
- VA State License 2021 - 2024
- NC State License 2022 - 2023
- PA State License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsUsefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus.Simran Grewal, Ninad Zaman, Louis Borgatta, Matthew Nudy, Andrew Foy
The American Journal of Cardiology. 2021-09-01 - 5 citationsThe Impact of Angiotensin Receptor-Neprilysin Inhibitors on Arrhythmias in Patients with Heart Failure: A Systematic Review and Meta-analysis.Hata Mujadzic, George S Prousi, Rebecca Napier, Sultan Siddique, Ninad Zaman
The Journal of Innovations in Cardiac Rhythm Management. 2022-09-01 - 14 citationsRedox regulation of hormone sensitive lipase: Potential role in the mechanism of MEHP-induced stimulation of basal steroid synthesis in MA-10 Leydig cellsChristine Zhou, Ninad Zaman, Yunbo Li, Daniel B. Martinez-Arguelles, Vassilios Papadopoulos
Reproductive Toxicology. 2019-04-01
Abstracts/Posters
- A Comparison of Rate Control Agents in Patients With Atrial Fibrillation: Follow-up Investigation of Affirm StudyNinad Zaman, Gerald Naccarelli and Andrew Foy, Circulation, 11/12/2020
- Colchicine for Secondary Prevention of Adverse Outcomes From Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled TrialsNinad Zaman, Simran Grewal, Louis Borgatta, Matthew Nudy, Brandon Peterson, Circulation, 11/12/2020
- Glucagon-like Peptide-1 Receptor Agonists Reduce Adverse Cardiovascular Disease (CVD) Events in Patients With Type 2 Diabetes: An Assessment of Heterogeneity Among CVD...Simran Grewal, Ninad Zaman, Louis Borgatta, Matthew Nudy, Brandon Peterson, Circulation, 11/12/2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: